Hospitalized women with ischemic stroke are less likely than men to be evaluated by stroke specialists and receive specialized imaging scans and other diagnostic testing in hospitals, according to research being presented at this year's American Stroke Association International Stroke Conference in Honolulu.

Direct oral anticoagulants (DOACs) are on their way to surpassing warfarin as the anticoagulant of choice among Medicaid beneficiaries, despite their higher cost, according to new research published in the Journal of the American College of Cardiology.

Despite the best current recommendations advocating women avoid mammograms before elective breast surgery, a large number of women still undergo pre-surgical screening, reported authors of a study published in JAMA Surgery. The unnecessary imaging may drive up healthcare costs and lead to unneeded tests.

Theranos, the $9 billion biotechnology startup that officially dissolved last year after allegations of fraud, is a warning for investors in life sciences. Namely, a lack of transparency within portfolio companies creates the possibility of another multibillion dollar implosion, according to researchers from the Meta-Research Innovation Center at Stanford.

How will the Protecting Access to Medicare Act (PAMA) of 2014 impact emergency department (ED) care in 2020 and beyond? That’s precisely what the authors of a new study published in Radiology wanted to find out.

“We believe that people should be able to play a more active role in managing their well-being,” Apple COO, Jeff Williams, said in a prepared statement. “As we learn over time, the goal is to make more customized recommendations that will help members accomplish their goals and live healthier lives.”

The 2.3 percent medical device tax, originally implemented as a piece of the Affordable Care Act, is currently suspended until 2020. Could 2019 be the year it gets repealed for good?

More than 40 percent of hospitals and other healthcare providers believe 3M’s $1 billion acquisition of M*Modal will have an overall positive impact in the market, according to a survey by Reaction Data.

Cancer patients who experienced tachycardia within one year of being diagnosed carried higher mortality rates up to a decade later—even after adjusting for clinical characteristics and medication use—according to research presented Jan. 25 at the Advancing the Cardiovascular Care of the Oncology Patient conference.